Stock listing
TSXV:TELO Telo Genomics Corp. Stock
Home listing (TSXV) of Telo Genomics Corp.
Follow Telo Genomics Corp. into a list and get an email when it puts out news.
Share price · TSXV:TELO
$0.05 CAD 0.00 (0.0%)
Close on Oct 30, 2026
- Day range
- $0.05 – $0.05 CADOct 30, 2026
- Volume
- 7,722 sharesOct 30, 2026
- Market cap
- $5.02M CADAt the close on Oct 30, 2026 · price × 100.4M shares outstanding
- 52-week range
- $0.025 – $0.105 CADLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $2,693 CADMedian day 5,000 shares · 24 days with no trades · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:TELO · Home | $0.05 CAD | 0.00 (0.0%) | 7,722 | $0.05 | $0.05 | $0.05 | $0.05 | Close on Oct 30, 2026 |
| OTC:TDSGF | $0.044 USD | 0.000 (0.0%) | — | $0.044 | $0.044 | $0.044 | $0.044 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · TSXV:TELO · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 7,722 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 10,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 5,000 | |
| $0.05 | -0.005 | -9.1% | $0.05 | $0.05 | $0.05 | 6,000 | |
| $0.055 | 0.00 | 0.0% | $0.055 | $0.055 | $0.055 | 0 | |
| $0.055 | -0.015 | -21.4% | $0.06 | $0.06 | $0.055 | 8,000 | |
| $0.07 | +0.01 | +16.7% | $0.07 | $0.07 | $0.07 | 1,000 | |
| $0.06 | 0.00 | 0.0% | $0.06 | $0.06 | $0.06 | 0 | |
| $0.06 | -0.01 | -14.3% | $0.07 | $0.07 | $0.06 | 101,022 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.075 | $0.08 | $0.07 | 258,354 | |
| $0.07 | +0.02 | +40.0% | $0.06 | $0.075 | $0.055 | 185,463 | |
| $0.05 | -0.005 | -9.1% | $0.055 | $0.055 | $0.05 | 36,000 | |
| $0.055 | +0.005 | +10.0% | $0.065 | $0.105 | $0.045 | 153,000 | |
| $0.05 | -0.005 | -9.1% | $0.055 | $0.06 | $0.05 | 54,100 | |
| $0.055 | -0.005 | -8.3% | $0.055 | $0.055 | $0.055 | 12,158 | |
| $0.06 | +0.01 | +20.0% | $0.05 | $0.065 | $0.05 | 300,352 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 5,000 | |
| $0.05 | +0.015 | +42.9% | $0.035 | $0.05 | $0.035 | 218,000 | |
| $0.035 | 0.00 | 0.0% | $0.035 | $0.035 | $0.025 | 425,500 | |
| $0.035 | 0.00 | 0.0% | $0.035 | $0.035 | $0.035 | 50,000 | |
| $0.035 | 0.00 | 0.0% | $0.035 | $0.035 | $0.035 | 0 | |
| $0.035 | 0.00 | 0.0% | $0.04 | $0.04 | $0.035 | 11,000 | |
| $0.035 | -0.005 | -12.5% | $0.04 | $0.04 | $0.035 | 51,400 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 3,550 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.05 | $0.035 | 184,000 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | -0.005 | -11.1% | $0.04 | $0.04 | $0.04 | 145,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.05 | $0.045 | 463,026 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | +0.005 | +12.5% | $0.045 | $0.045 | $0.045 | 40,000 | |
| $0.04 | 0.00 | 0.0% | $0.04 | $0.04 | $0.04 | 0 | |
| $0.04 | +0.005 | +14.3% | $0.04 | $0.04 | $0.04 | 102,000 | |
| $0.035 | -0.005 | -12.5% | $0.035 | $0.035 | $0.035 | 39,000 | |
| $0.04 | -0.005 | -11.1% | $0.045 | $0.045 | $0.04 | 133,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 3,015 | |
| $0.045 | -0.005 | -10.0% | $0.045 | $0.045 | $0.04 | 108,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 2,000 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | 0.00 | 0.0% | $0.05 | $0.05 | $0.05 | 0 | |
| $0.05 | +0.005 | +11.1% | $0.04 | $0.05 | $0.04 | 193,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 9,000 | |
| $0.045 | -0.005 | -10.0% | $0.045 | $0.045 | $0.045 | 50,000 | |
| $0.05 | +0.005 | +11.1% | $0.05 | $0.05 | $0.05 | 6,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 1,748 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 40,000 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | 0.00 | 0.0% | $0.045 | $0.045 | $0.045 | 0 | |
| $0.045 | -0.005 | -10.0% | $0.045 | $0.045 | $0.045 | 1,000 |
- Ticker
- TSXV:TELO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Oct 29, 2026
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
Latest deck · December 2025
Investor Presentation (December 2025)
Investor deck · 19 slides
Latest news
TELO Genomics Expands Multi-Center Clinical Studies to Advance Comparative Validation of TELO-MRD Against Next-Generation Sequencing
Oct 29, 2026
Closed $0.05 (0.0%) on Oct 29, 2026
Telo Genomics Reports Additional Clinical Research Results Comparing Blood-Based TELO-MRD with Bone-Marrow Next-Generation Flow and Next-Generation Sequencing
Sep 29, 2026
Closed $0.035 (0.0%) on Sep 29, 2026
Telo Genomics Announces Clinical Research Results Evidencing Utility of Its Telomere Analysis Platform in Predicting Multiple Myeloma Relapse
Sep 15, 2026
Closed $0.045 (0.0%) on Sep 15, 2026
Telo Genomics Grants Stock Options
Aug 4, 2026
Closed $0.045 (0.0%) on Aug 4, 2026
Telo Genomics Provides Positive Interim Data from Ongoing Clinical Trial Advancing Genomic Instability-Based Relapse Risk Assessment
Jul 16, 2026
Closed $0.045 (0.0%) on Jul 16, 2026
Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma
Jul 9, 2026
Closed $0.045 (+12.5%) on Jul 9, 2026
Telo Genomics Announces Termination of Investor Relations Agreement
Jun 26, 2026
Closed $0.04 (0.0%) on Jun 29, 2026
Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma
Apr 14, 2026
Closed $0.055 (0.0%) on Apr 14, 2026
Telo Genomics Announces Appointment of John Farlinger as CEO and Chairman
Mar 31, 2026
Closed $0.055 (+22.2%) on Mar 31, 2026
Telo Genomics Closes Second and Final Tranche of Convertible Debentures Financing
Mar 9, 2026
Closed $0.05 (+11.1%) on Mar 9, 2026
Decks
Investor Presentation (December 2025)
Investor deck · 19 slides · December 2025
Telo Genomics Corp. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 19 in the last 12 months · 92 in all · newest Oct 29, 2026 · oldest 2016
- Decks
- 1 deck · latest December 2025
Where Telo Genomics Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:TELO · Home listing · This page | TSXV | Canada | CAD |
| OTC:TDSGF | OTC | United States | USD |
| LS Exchange:A2PV0Q | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2PV0Q | Lang & Schwarz | Germany | EUR |
| Munich:3D0A | Munich | Germany | EUR |
| Cboe Canada:TELO | Cboe Canada | Canada | CAD |
| gettex:3D0A | gettex | Germany | EUR |
| Frankfurt:3D0A | Frankfurt | Germany | EUR |
| Stuttgart:3D0A | Stuttgart | Germany | EUR |
| Tradegate:3D0A | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Telo Genomics Corp.